SCHEMBL16534541

SCHEMBL16534541

CCOC(=O)c1cnn2c(=O)c(CC)c(C)[nH]c12

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 11/20 0.56
ALDH1A1 P00352 5/20 0.56
RAB9A P51151 3/20 0.56
HPGD P15428 3/20 0.56
HIF1A Q16665 1/20 0.56
PLAT P00750 3/20 0.51
NPC1 O15118 3/20 0.45
HSD17B10 Q99714 2/20 0.44
PKM P14618 1/20 0.44
MAPT P10636 5/20 0.43
L3MBTL1 Q9Y468 4/20 0.43
LMNA P02545 2/20 0.43
KMT2A Q03164 3/20 0.42
MAPK1 P28482 1/20 0.41
POLB P06746 4/20 0.41
TDP1 Q9NUW8 2/20 0.41
GAA P10253 2/20 0.41
MEN1 O00255 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8177312 0.89 KDM4E (0.53) KDM4EALDH1A1RAB9AHPGDHIF1A
SCHEMBL8190368 0.82 KDM4E (0.51) KDM4EALDH1A1RAB9AHPGDHIF1A
SCHEMBL16534821 0.82 PLAT (0.39) KDM4EALDH1A1RAB9AHPGDHIF1A
SCHEMBL16534841 0.82 KDM4E (0.39) KDM4EALDH1A1RAB9AHPGDHIF1A
SCHEMBL8191386 0.81 PLAT (0.49) KDM4EALDH1A1RAB9AHPGDHIF1A
SCHEMBL28050151 0.81 KDM4E (0.39) KDM4EALDH1A1RAB9AHPGDHIF1A
SCHEMBL8188074 0.79 KDM4E (0.50) KDM4EALDH1A1RAB9AHPGDHIF1A
SCHEMBL8191989 0.79 KDM4E (0.50) KDM4EALDH1A1RAB9AHPGDHIF1A
SCHEMBL16534582 0.79 KDM4E (0.34) KDM4EALDH1A1RAB9AHPGDHIF1A
SCHEMBL16534585 0.79 KDM4E (0.34) KDM4EALDH1A1RAB9AHPGDHIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3041474-B1 ANTIPROLIFERATIVE COMPOUNDS GENENTECH INC (US) 2020-03-18 EP disclosed
US-9505767-B2 Pyrazolo[1,5-A]pyrimidin-7(4H)-onehistone demethylase inhibitors GENENTECH, INC. (US) 2016-11-29 US disclosed
US-9505767-B2 Pyrazolo[1,5-A]pyrimidin-7(4H)-onehistone demethylase inhibitors GENENTECH, INC. (US) 2016-11-29 US disclosed
US-9505767-B2 Pyrazolo[1,5-A]pyrimidin-7(4H)-onehistone demethylase inhibitors GENENTECH, INC. (US) 2016-11-29 US disclosed
EP-3041474-A1 ANTIPROLIFERATIVE COMPOUNDS Genentech, Inc. (US) 2016-07-13 EP disclosed
WO-2015035062-A1 ANTIPROLIFERATIVE COMPOUNDS GENENTECH, INC. (US) 2015-03-12 WO disclosed
WO-2015035062-A1 ANTIPROLIFERATIVE COMPOUNDS GENENTECH, INC. (US) 2015-03-12 WO disclosed
US-20150065522-A1 THERAPEUTIC COMPOUNDS AND USES THEREOF GENENTECH, INC. 2015-03-05 US disclosed
US-20150065522-A1 THERAPEUTIC COMPOUNDS AND USES THEREOF GENENTECH, INC. 2015-03-05 US disclosed
US-20150065522-A1 THERAPEUTIC COMPOUNDS AND USES THEREOF GENENTECH, INC. 2015-03-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150065522-A1 THERAPEUTIC COMPOUNDS AND USES THEREOF KDM5A, KDM5B, KDM5C KDM4E 9/4885ALDH1A1 595/4885RAB9A 3262/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.